Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06718231Not ApplicableNot Yet Recruiting

TAES Alleviate Post-VATS Depression

Role: lead

NCT04883177Completed

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Role: collaborator

NCT02232997Not ApplicableCompleted

Simplified Rapid Hydration in Preventing CA-AKI Among Patients With Chronic Kidney Disease

Role: collaborator

NCT02575092Phase 2Completed

The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment

Role: lead

NCT02225210Phase 4Unknown

Effects of Dexmedetomidine Sedation on Delirium and Haemodynamic in Mechanical Ventilated Elderly Patients

Role: lead

NCT02129985Phase 4Unknown

Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

Role: collaborator

NCT00913315Not ApplicableUnknown

Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis

Role: collaborator

All 7 trials loaded